1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Myocardial Ischemia Global Clinical Trials Review, H2, 2014

Myocardial Ischemia Global Clinical Trials Review, H2, 2014

  • September 2014
  • -
  • Global Data
  • -
  • 71 pages

Myocardial Ischemia Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myocardial Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Myocardial Ischemia Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables4
List of Figures 5
Introduction 6
Myocardial Ischemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Myocardial Ischemia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Myocardial Ischemia Therapeutics Clinical Trials 30
Prominent Drugs 31
Latest Clinical Trials News on Myocardial Ischemia 32
Jun 12, 2014: Cardium To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 BIO International Convention 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Gilead Sciences, Inc. 34
Clinical Trial Overview of Gilead Sciences, Inc. 34
Abbott Laboratories 35
Clinical Trial Overview of Abbott Laboratories 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Merck and Co., Inc. 37
Clinical Trial Overview of Merck and Co., Inc. 37
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Medicure Inc. 39
Clinical Trial Overview of Medicure Inc. 39
Cytori Therapeutics, Inc. 40
Clinical Trial Overview of Cytori Therapeutics, Inc. 40
Baxter International Inc. 41
Clinical Trial Overview of Baxter International Inc. 41
Actavis plc 42
Clinical Trial Overview of Actavis plc 42
Clinical Trial Overview of Top Institutes / Government 43
National Heart, Lung, and Blood Institute 43
Clinical Trial Overview of National Heart, Lung, and Blood Institute 43
U.S. Department of Veterans Affairs 46
Clinical Trial Overview of U.S. Department of Veterans Affairs 46
Medical University of Vienna 47
Clinical Trial Overview of Medical University of Vienna 47
Imperial College London 48
Clinical Trial Overview of Imperial College London 48
Seoul National University Hospital 49
Clinical Trial Overview of Seoul National University Hospital 49
Hartford Hospital 50
Clinical Trial Overview of Hartford Hospital 50
Erasmus MC 51
Clinical Trial Overview of Erasmus MC 51
Ottawa Hospital Research Institute 52
Clinical Trial Overview of Ottawa Hospital Research Institute 52
Flinders Medical Centre 53
Clinical Trial Overview of Flinders Medical Centre 53
Assistance Publique - Hopitaux de Paris 54
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 54
Five Key Clinical Profiles 55
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 71

List of Tables
Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Myocardial Ischemia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Myocardial Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Myocardial Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 34
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 35
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 36
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2014* 37
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 38
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2014* 39
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014* 40
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014* 41
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 42
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 43
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 46
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014* 47
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014* 48
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014* 49
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hartford Hospital, 2014* 50
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 51
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014* 52
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Flinders Medical Centre, 2014* 53
Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 54

List of Figures
Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.